Nektar Therapeutics - Common Stock — Quarterly Financial Statistics (NASDAQ:NKTR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -49.05 M-45.74 M-48.76 M-64.96 M-44.3 M -203.76 M Cash from investing activities 43.69 M49.62 M-94.87 M372 K-350.79 M -395.68 M Cash from financing activities 7 000211 K141.68 M38.67 M529.55 M 710.11 M Free cash flow -49.05 M-45.74 M-48.76 M-64.96 M-44.3 M -203.76 M

News

Does Nektar (NKTR) Have the Potential to Rally 104.06% as Wall Street Analysts Expect?

Nektar: Sanofi’s Exit Clears A Competitor But Raises The Bar In Atopic Dermatitis (NKTR)

NKTR Up on Start of Phase III Program on Rezpeg for Atopic Dermatitis

Why I'm Still Neutral On Nektar Therapeutics After Alopecia Areata Extension Data (NKTR)

Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern

5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com

3 Best Healthcare Stocks to Buy in May 2026, According to Analysts - TipRanks.com

Nektar Q1 Earnings & Revenues Lag Estimates, Pipeline in Focus

Nektar Therapeutics (NKTR) Q1 2026 Earnings Call Transcript

Nektar Therapeutics: This Stock Went Up 10x In The Last Year And It's Still Cheap

Nektar (NKTR) Moves 18.3% Higher: Will This Strength Last?

Nektar Therapeutics (NKTR) Discusses 52-Week Topline Results From REZOLVE-AA Phase 2b Extension in Severe Alopecia Areata - Slideshow (NASDAQ:NKTR) 2026-04-20